Red Cell Survival: Relevance and Mechanism Involved

Journal of Renal Nutrition

Volumn 20, Issue 5, 2010, Pages S84-S88

  Handelman, Garry J ^a   Levin, Nathan W ^b  

^a UNIVERSITY OF MASSACHUSETTS LOWELL   (United States)

^b RENAL RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84943010112     PISSN: 10512276     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.jrn.2010.06.007     Document Type: Article

References (30)

1. Uehlinger, D.E., Gotch, F.A., Sheiner, L.B., A pharmacodynamic model of erythropoietin therapy for uremic anemia. Clin Pharmacol Ther 51 (1992), 76–89.
2. Strocchi, A., Schwartz, S., Ellefson, M., et al. A simple carbon monoxide breath test to estimate erythrocyte turnover. J Lab Clin Med 120 (1992), 392–399.
3. Medina, A., Ellis, C., Levitt, M.D., Use of alveolar carbon monoxide measurements to assess red blood cell survival in hemodialysis patients. Am J Hematol 46 (1994), 91–94.
4. Furne, J.K., Springfield, J.R., Ho, S.B., et al. Simplification of the end-alveolar carbon monoxide technique to assess erythrocyte survival. J Lab Clin Med 142 (2003), 52–57.
5. Mitlyng, B.L., Singh, J.A., Furne, J.K., et al. Use of breath carbon monoxide measurements to assess erythrocyte survival in subjects with chronic diseases. Am J Hematol 81 (2006), 432–438.
6. Nemeth, E., Rivera, S., Gabayan, V., et al. IL-6 mediates hypoferremia of inflammation by inducing the synthesis of the iron regulatory hormone hepcidin. J Clin Invest 113 (2004), 1271–1276.
7. Brugnara, C., Iron deficiency and erythropoiesis: new diagnostic approaches. Clin Chem 49 (2003), 1573–1578.
8. Ly, J., Marticorena, R., Donnelly, S., Red blood cell survival in chronic renal failure. Am J Kidney Dis 44 (2004), 715–719.
9. Bratosin, D., Mazurier, J., Tissier, J.P., et al. Molecular mechanisms of erythrophagocytosis. Characterization of the senescent erythrocytes that are phagocytized by macrophages. C R Acad Sci III 320 (1997), 811–818.
10. Bratosin, D., Mazurier, J., Debray, H., et al. Flow cytofluorimetric analysis of young and senescent human erythrocytes probed with lectins. Evidence that sialic acids control their life span. Glycoconj J 12 (1995), 258–267.
11. Henrich, C.J., Aminoff, D., Isolation and characterization of a glycopeptide from human senescent erythrocytes. Carbohydr Res 120 (1983), 55–66.
12. Dekkers, D.W., Comfurius, P., Bevers, E.M., et al. Comparison between Ca2+-induced scrambling of various fluorescently labelled lipid analogues in red blood cells. Biochem J 362 (2002), 741–747.
13. Brimble, K.S., Clase, C.M., Hemoglobin variability in dialysis patients. J Am Soc Nephrol 18 (2007), 2218–2220.
14. Alfrey, C.P., Rice, L., Udden, M.M., et al. Neocytolysis: physiological down-regulator of red-cell mass. Lancet 349 (1997), 1389–1390.
15. Savill, N.J., Chadwick, W., Reece, S.E., Quantitative analysis of mechanisms that govern red blood cell age structure and dynamics during anaemia. PLoS Comput Biol, 5, 2009, e1000416.
16. Rice, L., Alfrey, C.P., Modulation of red cell mass by neocytolysis in space and on Earth. Pflugers Arch 441 (2000), R91–R94.
17. Rice, L., Ruiz, W., Driscoll, T., et al. Neocytolysis on descent from altitude: a newly recognized mechanism for the control of red cell mass. Ann Intern Med 134 (2001), 652–656.
18. Rice, L., Alfrey, C.P., The negative regulation of red cell mass by neocytolysis: physiologic and pathophysiologic manifestations. Cell Physiol Biochem 15 (2005), 245–250.
19. Trial, J., Rice, L., Erythropoietin withdrawal leads to the destruction of young red cells at the endothelial-macrophage interface. Curr Pharm Des 10 (2004), 183–190.
20. Macdougall, L.G., Judisch, J.M., Mistry, S.B., Red cell metabolism in iron deficiency anemia II. The relationship between red cell survival and alterations in red cell metabolism. J Pediatr 76 (1970), 660–675.
21. Kempe, D.S., Lang, P.A., Duranton, C., et al. Enhanced programmed cell death of iron-deficient erythrocytes. FASEB J 20 (2006), 368–370.
22. Tyurina, Y.Y., Tyurin, V.A., Zhao, Q., et al. Oxidation of phosphatidylserine: a mechanism for plasma membrane phospholipid scrambling during apoptosis?. Biochem Biophys Res Commun 324 (2004), 1059–1064.
23. Cellerino, R., Guidi, G., Perona, G., Plasma iron and erythrocytic glutathione peroxidase activity. A possible mechanism for oxidative haemolysis in iron deficiency anemia. Scand J Haematol 17 (1976), 111–116.
24. Khandelwal, S., Saxena, R.K., A role of phosphatidylserine externalization in clearance of erythrocytes exposed to stress but not in eliminating aging populations of erythrocyte in mice. Exp Gerontol 43 (2008), 764–770.
25. Vaya, A., Simo, M., Santaolaria, M., et al. Red blood cell deformability in iron deficiency anaemia. Clin Hemorheol Microcirc 33 (2005), 75–80.
26. Fujita, J., Tsuda, K., Takeda, T., et al. Nisoldipine improves the impaired erythrocyte deformability correlating with elevated intracellular free calcium-ion concentration and poor glycaemic control in NIDDM. Br J Clin Pharmacol 47 (1999), 499–506.
27. Kiefer, C.R., Snyder, L.M., Oxidation and erythrocyte senescence. Curr Opin Hematol 7 (2000), 113–116.
28. Rice, L., Alfrey, C.P., Driscoll, T., et al. Neocytolysis contributes to the anemia of renal disease. Am J Kidney Dis 33 (1999), 59–62.
29. Bovy, C., Gothot, A., Delanaye, P., et al. Mature erythrocyte parameters as new markers of functional iron deficiency in haemodialysis: sensitivity and specificity. Nephrol Dial Transplant 22 (2007), 1156–1162.
30. Bonomini, M., Sirolli, V., Reale, M., et al. Involvement of phosphatidylserine exposure in the recognition and phagocytosis of uremic erythrocytes. Am J Kidney Dis 37 (2001), 807–814.